Squamous Cell Carcinomas of the Head and Neck Cancer Response to Programmed Cell Death Protein-1 Targeting and Differential Expression of Immunological Markers: A Case Report
<p dir="ltr">Targeting the programmed cell death protein-1 (PD-1)/PD-1 ligand (PD-L1) pathway has been shown to enhance T cell-mediated antitumor immunity. Clinical responses are limited to subgroups of patients. The search for biomarkers of response is a strategy to predict response...
محفوظ في:
| المؤلف الرئيسي: | Maysaloun Merhi (4246147) (author) |
|---|---|
| مؤلفون آخرون: | Afsheen Raza (492657) (author), Varghese Philipose Inchakalody (14153292) (author), Abdulqadir Jeprel Japer Nashwan (18090526) (author), Niloofar Allahverdi (14557403) (author), Roopesh Krishnankutty (1297770) (author), Shahab Uddin (154400) (author), Abdul Rehman Zar Gul (14777347) (author), Mohammed Ussama Al Homsi (15263542) (author), Said Dermime (79420) (author) |
| منشور في: |
2018
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives
حسب: Remy Thomas (702843)
منشور في: (2018) -
Treatment with decitabine induces the expression of stemness markers, PD-L1 and NY-ESO-1 in colorectal cancer: potential for combined chemoimmunotherapy
حسب: Nassiba Taib (14557385)
منشور في: (2023) -
Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy
حسب: Afsheen Raza (492657)
منشور في: (2022) -
The molecular mechanisms of apoptosis accompanied with the epigenetic regulation of the NY-ESO-1 antigen in non-small lung cancer cells treated with decitabine (5-aza-CdR)
حسب: Varghese P. Inchakalody (14557382)
منشور في: (2023) -
Curcumin-Mediated Degradation of S-Phase Kinase Protein 2 Induces Cytotoxic Effects in Human Papillomavirus-Positive and Negative Squamous Carcinoma Cells
حسب: Abdul Q. Khan (14153247)
منشور في: (2018)